ExploreFinding
Finding adverse
Androgen deprivation therapy in men with prostate cancer was associated with statistically significant worsening of depression scores on the PHQ-9 over 6 months compared to eugonadal controls.
Effect size0.93
CI95%CI= 0.04 to 1.82
Follow-up6 months
ComparatorMen with localized prostate cancer who had previously undergone prostatectomy and were in remission (eugonadal controls)
Effect summaryadverse; 0.93; CI: 95%CI= 0.04 to 1.82

Connected entities

Interventions
Conditions
Outcomes

Source

PMC5794536
Effects of Androgen Deprivation Therapy on Pain Perception, Quality-of-Life and Depression in Men with Prostate Cancer
Read on PMC → · View in graph →